VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VYCOR MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.24M
- P/E (TTM)
- –
- Dividend yield
- –
VYCOR MEDICAL INC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vycor Medical Inc [Member] | $1.80M | $1.52M | – | – | – | – | – | – | – | – | 96.4% | +18.5% |
| NovaVision Inc [Member] | $67.33K | $73.58K | – | – | – | – | – | – | – | – | 3.6% | -8.5% |
| Vycor Medical [Member] | – | $1.52M | $1.38M | $1.13M | $1.27M | $1.04M | $1.30M | $1.31M | $1.18M | $1.26M | – | – |
| NovaVision [Member] | – | $73.58K | $82.01K | $92.07K | $119.39K | $102.48K | $93.07K | $198.02K | $206.91K | $191.77K | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vycor Medical Inc [Member] | $493.79K | $353.05K | – | – | – | – | – | – | – | – | +39.9% |
| NovaVision Inc [Member] | -$183.88K | -$177.92K | – | – | – | – | – | – | – | – | +3.4% |
| Corporate Segment [Member] | -$276.01K | -$184.28K | -$151.85K | -$322.49K | – | – | – | – | – | – | +49.8% |
| Vycor Medical [Member] | – | $353.05K | $383.85K | $239.33K | – | – | – | – | – | – | – |
| NovaVision [Member] | – | -$177.92K | -$191.81K | -$223.35K | – | – | – | – | – | – | – |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.86M | $1.59M | $1.45M | $1.21M | $1.37M | $1.13M | $1.38M | $1.41M | $1.28M | – | 99.7% | +17.2% |
| Europe [Member] | $4.91K | $3.68K | $6.71K | $8.27K | $18.22K | $16.82K | $12.69K | $103.23K | $102.44K | $97.28K | 0.3% | +33.3% |
| United States [Member] | – | – | – | – | – | – | – | – | $1.28M | $1.36M | – | – |
From the segment and revenue-disaggregation notes of Vycor Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.